Background Morbidity after pancreatectomy is commonly due to leakage of exocrine
secretions resulting in abscess or pancreatic fistula (PF). Previously, we authored a double …

Background: Prospective randomized trials indicate that prophylactic octreotide treatment
does not decrease the incidence of postoperative pancreatic fistula (POPF). The aim of this …

[Prevention of pancreatic fistula after pancreatoduodenectomy]. - Abstract - Europe PMC Sign in
| Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …

Background. A meta‐analysis was conducted in order to provide an up‐to‐date comparison
of pancreatogastrostomy (PG) and pancreatojejunostomy (PJ), after …

Materials and Methods: Electronic databases, including PubMed, EMBASE, the Cochrane
library, and the Science Citation Index, were searched to retrieve relevant trials. In addition …

Pancreaticoduodenectomy is unquestionably the most difficult operation in major pancreatic
surgery as the result of both problems posed by perioperative management of the patients …

Background Preoperative chemotherapy (PCHT) has recently been proposed also in
patients with resectable pancreatic adenocarcinoma. Few data are currently available on the …

Objective This study seeks to evaluate the role of the somatostatin analogue Octreotide as
postoperative prophylaxis in the prevention of pancreatic fistula following …

The field of pancreatic surgery has considerably evolved in recent decades. The current
postoperative mortality rates have drastically improved and presently range between 2 …

Background In the past decades, the perioperative management of patients undergoing
pancreaticoduodenectomy (PD) has undergone major changes worldwide. This review …